Appointments at PharmaNet, Albemarle, VGXI and Ocimum Biosolutions – People on the move
Carl Spalding has joined the board of directors at PharmaNet Development. Spalding was previously president and chief operating officer of Parexel and has also worked at Cardinal Health, Abbott Laboratories and Johnson & Johnson.
Albemarle has appointed Nicole Daniel as vice president (VP), chief compliance officer and corporate secretary. Daniel is assistant general council at Albemarle, a position she will continue in, and has previously worked at law firms.
Yvonne Verburgt has joined Avrio Biopharmaceuticals as VP of business development and marketing. Verburgt has more than 28 years experience in the pharma industry at a number of companies, including Pharmatek Laboratories, Patheon and Becton Dickinson.
VGXI has made three appointments. Firstly, David Weiner has joined the company’s scientific advisory board. Weiner is chairman of Inovio Biomedical’s scientific advisory board and professor of pathology and laboratory medicine at the University of Pennsylvania, US.
Also, Sandra Jones has been named as director of validation and David Colvin has been appointed as key account manager. Jones joins from Beckman-Coulter and Colvin from Merck & Co.
David U’Prichard has joined the board of directors at Ocimum Biosolutions. U’Prichard also holds board positions at Life Technologies, Oxagen, Cyclacel and Silence Therapeutics.
AmerisourceBergen has re-elected Richard Gochnauer, Edward Hagenlocker and Henry McGee to its board of directors.
John Ferris has been appointed as director of manufacturing engineering at Millstone Medical Outsourcing. Ferris has more than 25 years of manufacturing and engineering experience at companies including DePuy and Flexcon Industries.
